Compare Stocks → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:APOPOTCMKTS:ECIANASDAQ:NVIVNASDAQ:OBLNNYSE:RMED Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPOPCellect Biotechnology$13.17+0.4%$11.51$6.64▼$35.52$12.87M1.87479,845 shs17,400 shsECIAEncision$0.75$0.46$0.25▼$0.75$8.83M0.282,180 shsN/ANVIVInVivo Therapeutics$0.58$0.22▼$2.40$997K0.658.25 million shs1.89 million shsOBLNObalon Therapeutics$0.18+1.8%$4.22$0.66▼$10.77$1.85M-1.237.68 million shs756,830 shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPOPCellect Biotechnology0.00%0.00%0.00%0.00%0.00%ECIAEncision+50.00%+50.00%+63.76%+76.47%+79.00%NVIVInVivo Therapeutics0.00%0.00%0.00%-56.07%-68.24%OBLNObalon Therapeutics0.00%+1.80%+19.60%-29.11%-93.82%RMEDRa Medical Systems0.00%0.00%0.00%0.00%-60.66%A lot of people are making this costly mistake (Ad)You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next oneMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPOPCellect BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPOPCellect BiotechnologyN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPOPCellect BiotechnologyN/AN/AN/AN/A$4.77 per shareN/AECIAEncision$7.35M1.20N/AN/A$0.21 per share3.57NVIVInVivo TherapeuticsN/AN/AN/AN/A$6.48 per shareN/AOBLNObalon Therapeutics$1.59M1.16N/AN/A$0.60 per share0.31RMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPOPCellect Biotechnology-$5.62MN/A0.00∞N/AN/AN/AN/AN/AECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)NVIVInVivo Therapeutics-$10.49MN/A0.00N/AN/AN/A-75.04%-65.01%N/AOBLNObalon Therapeutics-$12.33MN/AN/A∞N/A-776.76%-161.38%-83.58%N/ARMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ALatest APOP, NVIV, ECIA, RMED, and OBLN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPOPCellect BiotechnologyN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPOPCellect BiotechnologyN/A3.013.01ECIAEncision0.112.551.08NVIVInVivo TherapeuticsN/A14.3014.30OBLNObalon TherapeuticsN/A1.861.86RMEDRa Medical SystemsN/A2.862.85OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPOPCellect Biotechnology4.84%ECIAEncision8.20%NVIVInVivo Therapeutics13.78%OBLNObalon Therapeutics18.64%RMEDRa Medical Systems11.00%Insider OwnershipCompanyInsider OwnershipAPOPCellect BiotechnologyN/AECIAEncision40.87%NVIVInVivo Therapeutics2.45%OBLNObalon Therapeutics8.10%RMEDRa Medical Systems18.62%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPOPCellect Biotechnology2,020977,000N/ANot OptionableECIAEncision3111.78 million6.96 millionNot OptionableNVIVInVivo Therapeutics63.11 million3.03 millionNot OptionableOBLNObalon Therapeutics210.02 millionN/ANot OptionableRMEDRa Medical Systems145.37 million4.37 millionNot OptionableAPOP, NVIV, ECIA, RMED, and OBLN HeadlinesSourceHeadlineDietary Interventions Reduce CVD Risk in RA and SpAajmc.com - March 8 at 7:57 PMAlert1 Medical Alert System Review: What Experts Say (2024)forbes.com - February 20 at 9:27 PMRa Medical Systems Inc.thestreet.com - February 15 at 10:42 AMCatheter Precision Inc (VTAK)investing.com - February 11 at 11:09 PMVTAK Catheter Precision, Inc.seekingalpha.com - January 19 at 6:41 PMWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By Doctorsmsn.com - January 7 at 11:58 PMCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Qfinance.yahoo.com - August 25 at 6:53 PMReminder: Ra Medical Systems Announces Name and Ticker Symbol Changesfinance.yahoo.com - August 17 at 9:15 AMRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device Patentfinanznachrichten.de - August 16 at 6:14 PMRa Medical Systems Announces Milestone Achievement for Electrophysiology Divisionfinance.yahoo.com - August 7 at 12:14 PMRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol Changesfinanznachrichten.de - August 2 at 8:13 AMRa Medical says demand is rising for its non-invasive electrophysiology mapping systemmassdevice.com - July 24 at 5:15 PMRa Medical Systems, Inc.: Ra Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinanznachrichten.de - July 24 at 12:14 PMRa Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinance.yahoo.com - July 24 at 12:14 PMRa Medical Systems, Inc.: RMED's LockeT Device Utilized in Structural Heart Proceduresfinanznachrichten.de - July 6 at 10:17 AMRMED's LockeT Device Utilized in Structural Heart Proceduresfinance.yahoo.com - July 6 at 10:17 AMInvesting in Ra Medical Systems Inc (RMED): What You Must Knowknoxdaily.com - July 5 at 6:18 PMRa Medical Systems, Inc.: RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finanznachrichten.de - June 28 at 9:07 AMRMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finance.yahoo.com - June 28 at 9:07 AMRa Medical Systems, Inc.: Ra Medical's Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinanznachrichten.de - June 12 at 4:10 PMRa Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinance.yahoo.com - June 12 at 4:10 PMMedical Device Co. Completes Merger in Q1/23investorideas.com - June 9 at 9:35 PMRa Medical Systems reports Q1 resultsmsn.com - June 5 at 10:34 AMRa Medical Systems, Inc.: Ra Medical Systems Announces First Quarter Resultsfinanznachrichten.de - June 2 at 9:16 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines4 Oversold Large Cap Stocks Yielding High DividendsMarch 14, 2024 6:30 AMView 4 Oversold Large Cap Stocks Yielding High DividendsMicron Stock: Why $100 per Share is Just the StartMarch 8, 2024 10:10 AMView Micron Stock: Why $100 per Share is Just the StartSamsara Stock Nears Major Breakout Ahead of Upcoming EarningsMarch 7, 2024 6:10 AMView Samsara Stock Nears Major Breakout Ahead of Upcoming EarningsMcCormick & Company Stock Isn’t Cheap, But It Is UndervaluedMarch 26, 2024 10:28 AMView McCormick & Company Stock Isn’t Cheap, But It Is UndervaluedHow and When to Roll Your Options Positions? March 27, 2024 9:32 AMView How and When to Roll Your Options Positions? All Headlines Company DescriptionsCellect BiotechnologyNASDAQ:APOPCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.InVivo TherapeuticsNASDAQ:NVIVInVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.Obalon TherapeuticsNASDAQ:OBLNObalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.Ra Medical SystemsNYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.